Meningitis PDF
Meningitis PDF
1
2 2 CAUSES
tuation maneuver” helps determine whether meningitis is fections may result in hemorrhaging of the adrenal glands,
present in those reporting fever and headache. A person leading to Waterhouse-Friderichsen syndrome, which is
is asked to rapidly rotate the head horizontally; if this does often fatal.[18]
not make the headache worse, meningitis is unlikely.[13] The brain tissue may swell, pressure inside the skull may
Meningitis caused by the bacterium Neisseria menin- increase and the swollen brain may herniate through the
gitidis (known as “meningococcal meningitis”) can be skull base. This may be noticed by a decreasing level
differentiated from meningitis with other causes by a of consciousness, loss of the pupillary light reflex, and
rapidly spreading petechial rash, which may precede abnormal posturing.[3] The inflammation of the brain tis-
other symptoms.[14] The rash consists of numerous small, sue may also obstruct the normal flow of CSF around the
irregular purple or red spots (“petechiae”) on the trunk, brain (hydrocephalus).[3] Seizures may occur for various
lower extremities, mucous membranes, conjuctiva, and reasons; in children, seizures are common in the early
(occasionally) the palms of the hands or soles of the feet. stages of meningitis (in 30% of cases) and do not neces-
The rash is typically non-blanching; the redness does not sarily indicate an underlying cause.[5] Seizures may result
disappear when pressed with a finger or a glass tumbler. from increased pressure and from areas of inflammation
Although this rash is not necessarily present in meningo- in the brain tissue.[3] Focal seizures (seizures that involve
coccal meningitis, it is relatively specific for the disease; one limb or part of the body), persistent seizures, late-
it does, however, occasionally occur in meningitis due to onset seizures and those that are difficult to control with
other bacteria.[1] Other clues on the cause of meningitis medication indicate a poorer long-term outcome.[1]
may be the skin signs of hand, foot and mouth disease and Inflammation of the meninges may lead to abnormali-
genital herpes, both of which are associated with various ties of the cranial nerves, a group of nerves arising from
forms of viral meningitis.[17] the brain stem that supply the head and neck area and
which control, among other functions, eye movement,
1.2 Early complications facial muscles, and hearing.[1][13] Visual symptoms and
hearing loss may persist after an episode of meningitis.[1]
Inflammation of the brain (encephalitis) or its blood ves-
sels (cerebral vasculitis), as well as the formation of blood
clots in the veins (cerebral venous thrombosis), may all
lead to weakness, loss of sensation, or abnormal move-
ment or function of the part of the body supplied by the
affected area of the brain.[1][3]
2 Causes
connective tissue disorders such as systemic lupus ery- the meninges and leading to “interstitial” edema (swelling
thematosus, and certain forms of vasculitis (inflammatory due to fluid between the cells). In addition, the walls
conditions of the blood vessel wall), such as Behçet’s dis- of the blood vessels themselves become inflamed (cere-
ease.[4] Epidermoid cysts and dermoid cysts may cause bral vasculitis), which leads to decreased blood flow and a
meningitis by releasing irritant matter into the subarach- third type of edema, “cytotoxic” edema. The three forms
noid space.[4][23] Rarely, migraine may cause meningitis, of cerebral edema all lead to increased intracranial pres-
but this diagnosis is usually only made when other causes sure; together with the lowered blood pressure often en-
have been eliminated.[4] countered in acute infection, this means that it is harder
for blood to enter the brain, consequently brain cells are
deprived of oxygen and undergo apoptosis (programmed
3 Mechanism cell death).[1]
It is recognized that administration of antibiotics may
The meninges comprise three membranes that, together initially worsen the process outlined above, by increas-
with the cerebrospinal fluid, enclose and protect the brain ing the amount of bacterial cell membrane products
and spinal cord (the central nervous system). The pia released through the destruction of bacteria. Particu-
mater is a very delicate impermeable membrane that lar treatments, such as the use of corticosteroids, are
firmly adheres to the surface of the brain, following all the aimed at dampening the immune system’s response to this
minor contours. The arachnoid mater (so named because phenomenon.[1][3]
of its spider-web-like appearance) is a loosely fitting sac
on top of the pia mater. The subarachnoid space separates
the arachnoid and pia mater membranes and is filled with 4 Diagnosis
cerebrospinal fluid. The outermost membrane, the dura
mater, is a thick durable membrane, which is attached to 4.1 Blood tests and imaging
both the arachnoid membrane and the skull.
In bacterial meningitis, bacteria reach the meninges by In someone suspected of having meningitis, blood tests
one of two main routes: through the bloodstream or are performed for markers of inflammation (e.g. C-
through direct contact between the meninges and either reactive protein, complete blood count), as well as blood
the nasal cavity or the skin. In most cases, meningitis fol- cultures.[5][37]
lows invasion of the bloodstream by organisms that live The most important test in identifying or ruling out
upon mucous surfaces such as the nasal cavity. This is meningitis is analysis of the cerebrospinal fluid through
often in turn preceded by viral infections, which break lumbar puncture (LP, spinal tap).[38] However, lumbar
down the normal barrier provided by the mucous sur- puncture is contraindicated if there is a mass in the brain
faces. Once bacteria have entered the bloodstream, they (tumor or abscess) or the intracranial pressure (ICP) is
enter the subarachnoid space in places where the blood– elevated, as it may lead to brain herniation. If someone
brain barrier is vulnerable—such as the choroid plexus. is at risk for either a mass or raised ICP (recent head in-
Meningitis occurs in 25% of newborns with bloodstream jury, a known immune system problem, localizing neu-
infections due to group B streptococci; this phenomenon rological signs, or evidence on examination of a raised
is less common in adults.[1] Direct contamination of the ICP), a CT or MRI scan is recommended prior to the
cerebrospinal fluid may arise from indwelling devices, lumbar puncture.[5][37][39] This applies in 45% of all adult
skull fractures, or infections of the nasopharynx or the cases.[3] If a CT or MRI is required before LP, or if
nasal sinuses that have formed a tract with the subarach- LP proves difficult, professional guidelines suggest that
noid space (see above); occasionally, congenital defects antibiotics should be administered first to prevent delay
of the dura mater can be identified.[1] in treatment,[5] especially if this may be longer than 30
[37][39]
The large-scale inflammation that occurs in the subarach- minutes. Often, CT or MRI scans are performed at
[1]
noid space during meningitis is not a direct result of bac- a later stage to assess for complications of meningitis.
terial infection but can rather largely be attributed to the In severe forms of meningitis, monitoring of blood elec-
response of the immune system to the entry of bacteria trolytes may be important; for example, hyponatremia is
into the central nervous system. When components of common in bacterial meningitis, due to a combination of
the bacterial cell membrane are identified by the immune factors, including dehydration, the inappropriate secre-
cells of the brain (astrocytes and microglia), they respond tion of the antidiuretic hormone (SIADH), or overly ag-
by releasing large amounts of cytokines, hormone-like gressive intravenous fluid administration.[3][40]
mediators that recruit other immune cells and stimulate
other tissues to participate in an immune response. The
blood–brain barrier becomes more permeable, leading to 4.2 Lumbar puncture
“vasogenic” cerebral edema (swelling of the brain due
to fluid leakage from blood vessels). Large numbers of A lumbar puncture is done by positioning the per-
white blood cells enter the CSF, causing inflammation of son, usually lying on the side, applying local anes-
4.3 Postmortem 5
5.3 Antibiotics
5.2 Vaccination
Short-term antibiotic prophylaxis is another method of
prevention, particularly of meningococcal meningitis. In
Since the 1980s, many countries have included
cases of meningococcal meningitis, preventative treat-
immunization against Haemophilus influenzae type
ment in close contacts with antibiotics (e.g. rifampicin,
B in their routine childhood vaccination schemes. This
ciprofloxacin or ceftriaxone) can reduce their risk of con-
has practically eliminated this pathogen as a cause of
tracting the condition, but does not protect against fu-
meningitis in young children in those countries. In the
ture infections.[37][57] Resistance to rifampicin has been
countries in which the disease burden is highest, how-
noted to increase after use, which has caused some to
ever, the vaccine is still too expensive.[47][48] Similarly,
recommend considering other agents.[57] While antibi-
immunization against mumps has led to a sharp fall in the
otics are frequently used in an attempt to prevent menin-
number of cases of mumps meningitis, which prior to
gitis in those with a basilar skull fracture there is not
vaccination occurred in 15% of all cases of mumps.[17]
enough evidence to determine whether this is beneficial
Meningococcus vaccines exist against groups A, B, C, or harmful.[58] This applies to those with or without a CSF
W135 and Y.[49][50][51] In countries where the vaccine for leak.[58]
meningococcus group C was introduced, cases caused by
this pathogen have decreased substantially.[47] A quadri-
valent vaccine now exists, which combines all four vac-
cines. Immunization with the ACW135Y vaccine against 6 Management
four strains is now a visa requirement for taking part
in Hajj.[52] Development of a vaccine against group B Meningitis is potentially life-threatening and has a high
meningococci has proved much more difficult, as its sur- mortality rate if untreated;[5] delay in treatment has been
face proteins (which would normally be used to make a associated with a poorer outcome.[3] Thus, treatment with
vaccine) only elicit a weak response from the immune sys- wide-spectrum antibiotics should not be delayed while
tem, or cross-react with normal human proteins.[47][49] confirmatory tests are being conducted.[39] If meningo-
6.1 Bacterial meningitis 7
coccal disease is suspected in primary care, guidelines a head injury, whether the person has undergone re-
recommend that benzylpenicillin be administered before cent neurosurgery and whether or not a cerebral shunt is
transfer to hospital.[14] Intravenous fluids should be ad- present.[5] In young children and those over 50 years of
ministered if hypotension (low blood pressure) or shock age, as well as those who are immunocompromised, the
are present.[39] In children routine intravenous fluids for addition of ampicillin is recommended to cover Listeria
two days may improve outcomes in those who arrive at monocytogenes.[5][37] Once the Gram stain results become
hospital after being sick for some time.[59] Given that available, and the broad type of bacterial cause is known,
meningitis can cause a number of early severe complica- it may be possible to change the antibiotics to those likely
tions, regular medical review is recommended to identify to deal with the presumed group of pathogens.[5] The re-
these complications early[39] and to admit the person to sults of the CSF culture generally take longer to become
an intensive care unit if deemed necessary.[3] available (24–48 hours). Once they do, empiric therapy
Mechanical ventilation may be needed if the level of may be switched to specific antibiotic therapy targeted
to the specific causative organism and its sensitivities to
consciousness is very low, or if there is evidence of
respiratory failure. If there are signs of raised in- antibiotics.[5] For an antibiotic to be effective in menin-
tracranial pressure, measures to monitor the pressure gitis it must not only be active against the pathogenic
may be taken; this would allow the optimization of the bacterium but also reach the meninges in adequate quan-
cerebral perfusion pressure and various treatments to de- tities; some antibiotics have inadequate penetrance and
crease the intracranial pressure with medication (e.g. therefore have little use in meningitis. Most of the an-
mannitol).[3] Seizures are treated with anticonvulsants.[3] tibiotics used in meningitis have not been tested directly
Hydrocephalus (obstructed flow of CSF) may require in- on people with meningitis in clinical trials. Rather, the
sertion of a temporary or long-term drainage device, such relevant knowledge has mostly derived from laboratory
as a cerebral shunt.[3] studies in rabbits.[5] Tuberculous meningitis requires pro-
longed treatment with antibiotics. While tuberculosis of
the lungs is typically treated for six months, those with
tuberculous meningitis are typically treated for a year or
6.1 Bacterial meningitis longer.[22]
6.1.1 Antibiotics
6.1.2 Steroids
decreased dramatically since the introduction of the Hib fluid,[1] the severity of the generalized illness, a decreased
vaccine. Thus, corticosteroids are recommended in the level of consciousness or an abnormally low count of
treatment of pediatric meningitis if the cause is H. in- white blood cells in the CSF.[3] Meningitis caused by
fluenzae, and only if given prior to the first dose of an- H. influenzae and meningococci has a better prognosis
tibiotics; other uses are controversial.[5] than cases caused by group B streptococci, coliforms and
S. pneumonia.[1] In adults, too, meningococcal menin-
gitis has a lower mortality (3–7%) than pneumococcal
6.2 Viral meningitis disease.[3]
In children there are several potential disabilities which
Viral meningitis typically only requires supportive ther-
may result from damage to the nervous system, includ-
apy; most viruses responsible for causing meningitis are
ing sensorineural hearing loss, epilepsy, learning and be-
not amenable to specific treatment. Viral meningitis
havioral difficulties, as well as decreased intelligence.[1]
tends to run a more benign course than bacterial menin-
These occur in about 15% of survivors.[1] Some of the
gitis. Herpes simplex virus and varicella zoster virus
hearing loss may be reversible.[69] In adults, 66% of all
may respond to treatment with antiviral drugs such as
cases emerge without disability. The main problems are
aciclovir, but there are no clinical trials that have specif-
deafness (in 14%) and cognitive impairment (in 10%).[3]
ically addressed whether this treatment is effective.[17]
Mild cases of viral meningitis can be treated at home Tuberculous meningitis in children continues to be as-
with conservative measures such as fluid, bedrest, and sociated with a significant risk of death even with treat-
analgesics.[66] ment (19%), and a significant proportion of the surviving
children have ongoing neurological problems. Just over a
third of all cases survives with no problems.[70]
6.3 Fungal meningitis
7 Prognosis
can last two to three years, dying out during the inter- Simon Flexner and markedly decreased mortality from
vening rainy seasons.[74] Attack rates of 100–800 cases meningococcal disease.[82][83] In 1944, penicillin was first
per 100,000 are encountered in this area,[75] which is reported to be effective in meningitis.[84] The introduc-
poorly served by medical care. These cases are predomi- tion in the late 20th century of Haemophilus vaccines led
nantly caused by meningococci.[13] The largest epidemic to a marked fall in cases of meningitis associated with this
ever recorded in history swept across the entire region pathogen,[48] and in 2002, evidence emerged that treat-
in 1996–1997, causing over 250,000 cases and 25,000 ment with steroids could improve the prognosis of bacte-
deaths.[76] rial meningitis.[61][64][83]
Meningococcal disease occurs in epidemics in areas
where many people live together for the first time, such as
army barracks during mobilization, college campuses[1] 10 References
and the annual Hajj pilgrimage.[52] Although the pattern
of epidemic cycles in Africa is not well understood, sev- [1] Sáez-Llorens X, McCracken GH (June 2003). “Bacterial
eral factors have been associated with the development meningitis in children”. Lancet 361 (9375): 2139–48.
of epidemics in the meningitis belt. They include: med- doi:10.1016/S0140-6736(03)13693-8. PMID 12826449.
ical conditions (immunological susceptibility of the pop-
ulation), demographic conditions (travel and large pop- [2] “Bacterial Meningitis”. CDC. April 1, 2014. Retrieved 5
ulation displacements), socioeconomic conditions (over- March 2016.
crowding and poor living conditions), climatic condi-
[3] van de Beek D, de Gans J, Tunkel AR, Wijdicks EF (Jan-
tions (drought and dust storms), and concurrent infections uary 2006). “Community-acquired bacterial meningitis
(acute respiratory infections).[75] in adults”. The New England Journal of Medicine 354 (1):
There are significant differences in the local distribution 44–53. doi:10.1056/NEJMra052116. PMID 16394301.
of causes for bacterial meningitis. For instance, while N.
[4] Ginsberg L (March 2004). “Difficult and recur-
meningitides groups B and C cause most disease episodes
rent meningitis” (PDF). Journal of Neurology, Neuro-
in Europe, group A is found in Asia and continues to pre- surgery, and Psychiatry. 75 Suppl 1 (90001): i16–21.
dominate in Africa, where it causes most of the major doi:10.1136/jnnp.2003.034272. PMC 1765649. PMID
epidemics in the meningitis belt, accounting for about 14978146.
80% to 85% of documented meningococcal meningitis
cases.[75] [5] Tunkel AR; Hartman BJ; Kaplan SL; et al. (November
2004). “Practice guidelines for the management of bacte-
rial meningitis” (PDF). Clinical Infectious Diseases 39 (9):
1267–84. doi:10.1086/425368. PMID 15494903.
9 History
[6] “Viral Meningitis”. CDC. November 26, 2014. Retrieved
5 March 2016.
Some suggest that Hippocrates may have realized the ex-
istence of meningitis,[13] and it seems that meningism [7] Global Burden of Disease Study 2013, Collaborators (22
was known to pre-Renaissance physicians such as August 2015). “Global, regional, and national incidence,
Avicenna.[77] The description of tuberculous meningitis, prevalence, and years lived with disability for 301 acute
then called "dropsy in the brain”, is often attributed to and chronic diseases and injuries in 188 countries, 1990-
Edinburgh physician Sir Robert Whytt in a posthumous 2013: a systematic analysis for the Global Burden of Dis-
report that appeared in 1768, although the link with tu- ease Study 2013.”. Lancet (London, England) 386 (9995):
berculosis and its pathogen was not made until the next 743–800. PMID 26063472.
century.[77][78]
[8] GBD 2013 Mortality and Causes of Death, Collabora-
It appears that epidemic meningitis is a relatively recent tors (17 December 2014). “Global, regional, and national
phenomenon.[79] The first recorded major outbreak oc- age-sex specific all-cause and cause-specific mortality for
curred in Geneva in 1805.[79][80] Several other epidemics 240 causes of death, 1990–2013: a systematic analysis for
in Europe and the United States were described shortly the Global Burden of Disease Study 2013.”. Lancet 385
(9963): 117–71. doi:10.1016/S0140-6736(14)61682-2.
afterward, and the first report of an epidemic in Africa
PMC 4340604. PMID 25530442.
appeared in 1840. African epidemics became much more
common in the 20th century, starting with a major epi- [9] “Meningococcal meningitis Fact sheet N°141”. WHO.
demic sweeping Nigeria and Ghana in 1905–1908.[79] November 2015. Retrieved 5 March 2016.
The first report of bacterial infection underlying menin-
[10] Mosby’s pocket dictionary of medicine, nursing & health
gitis was by the Austrian bacteriologist Anton Weich-
[81] professions (6th ed.). St. Louis, Mo.: Mosby/Elsevier.
selbaum, who in 1887 described the meningococcus. 2010. p. traumatic meningitis. ISBN 9780323066044.
Mortality from meningitis was very high (over 90%) in
early reports. In 1906, antiserum was produced in horses; [11] Liddell HG, Scott R (1940). "μήνιγξ". A Greek-English
this was developed further by the American scientist Lexicon. Oxford: Clarendon Press.
10 10 REFERENCES
[12] van de Beek D, de Gans J, Spanjaard L, Weisfelt M, [24] Shalabi, M.; Whitley, R. J. (1 November 2006).
Reitsma JB, Vermeulen M (October 2004). “Clinical “Recurrent Benign Lymphocytic Meningitis”.
features and prognostic factors in adults with bacterial Clinical Infectious Diseases 43 (9): 1194–1197.
meningitis”. The New England Journal of Medicine 351 doi:10.1086/508281. PMID 17029141.
(18): 1849–59. doi:10.1056/NEJMoa040845. PMID
15509818. [25] Raman Sharma R (2010). “Fungal infections of
the nervous system: current perspective and con-
[13] Attia J, Hatala R, Cook DJ, Wong JG (July 1999). “The troversies in management”. International journal
rational clinical examination. Does this adult patient have of surgery (London, England) 8 (8): 591–601.
acute meningitis?". Journal of the American Medical As- doi:10.1016/j.ijsu.2010.07.293. PMID 20673817.
sociation 282 (2): 175–81. doi:10.1001/jama.282.2.175.
[26] Sirven JI, Malamut BL (2008). Clinical neurology of
PMID 10411200.
the older adult (2nd ed.). Philadelphia: Wolters Kluwer
[14] Theilen U, Wilson L, Wilson G, Beattie JO, Qureshi Health/Lippincott Williams & Wilkins. p. 439. ISBN
S, Simpson D (June 2008). “Management of invasive 978-0-7817-6947-1.
meningococcal disease in children and young people: [27] Honda H, Warren DK (September 2009). “Central ner-
Summary of SIGN guidelines”. BMJ (Clinical research vous system infections: meningitis and brain abscess”. In-
ed.) 336 (7657): 1367–70. doi:10.1136/bmj.a129. PMC fectious disease clinics of North America 23 (3): 609–23.
2427067. PMID 18556318. doi:10.1016/j.idc.2009.04.009. PMID 19665086.
[15] Management of invasive meningococcal disease in children [28] Kauffman CA, Pappas PG, Patterson TF (19 October
and young people (PDF). Edinburgh: Scottish Intercolle- 2012). “Fungal infections associated with contaminated
giate Guidelines Network (SIGN). May 2008. ISBN 978- methyprednisolone injections—preliminary report”. New
1-905813-31-5. England Journal of Medicine. Online first (26): 2495–
500. doi:10.1056/NEJMra1212617. PMID 23083312.
[16] Thomas KE, Hasbun R, Jekel J, Quagliarello VJ (July
2002). “The diagnostic accuracy of Kernig’s sign, [29] Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (1
Brudzinski neck sign, and nuchal rigidity in adults with January 2011). Essentials of clinical mycology (2nd ed.).
suspected meningitis” (PDF). Clinical Infectious Diseases New York: Springer. p. 77. ISBN 978-1-4419-6639-1.
35 (1): 46–52. doi:10.1086/340979. PMID 12060874.
[30] Durski, Kara N.; Kuntz, Karen M.; Yasukawa, Kosuke;
[17] Logan SA, MacMahon E (January 2008). “Viral menin- Virnig, Beth A.; Meya, David B.; Boulware, David R.
gitis”. BMJ (Clinical research ed.) 336 (7634): 36– (Jul 1, 2013). “Cost-Effective Diagnostic Checklists
40. doi:10.1136/bmj.39409.673657.AE. PMC 2174764. for Meningitis in Resource-Limited Settings”. JAIDS
PMID 18174598. Journal of Acquired Immune Deficiency Syndromes 63
(3): e101–e108. doi:10.1097/QAI.0b013e31828e1e56.
[18] Varon J, Chen K, Sternbach GL (1998). “Rupert Water- PMID 23466647.
house and Carl Friderichsen: adrenal apoplexy”. J Emerg
Med 16 (4): 643–7. doi:10.1016/S0736-4679(98)00061- [31] Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (1
4. PMID 9696186. January 2011). Essentials of clinical mycology (2nd ed.).
New York: Springer. p. 31. ISBN 978-1-4419-6639-1.
[19] “Listeria (Listeriosis)". Centers for Disease Control and
Prevention. 22 October 2015. Retrieved 2015-12-23. [32] Park, Benjamin J; Park BJ; Wannemuehler KA; Marston
BJ; Govender N; Pappas PG; Chiller TM. (1 Febru-
[20] Hsu HE; Shutt KA; Moore MR; et al. (2009). “Ef- ary 2009). “Estimation of the current global bur-
fect of pneumococcal conjugate vaccine on pneumococ- den of cryptococcal meningitis among persons liv-
cal meningitis”. N Engl J Med 360 (3): 244–256. ing with HIV/AIDS”. AIDS 23 (4): 525–530.
doi:10.1056/NEJMoa0800836. PMID 19144940. doi:10.1097/QAD.0b013e328322ffac. PMID 19182676.
[21] Wei BP, Robins-Browne RM, Shepherd RK, Clark GM, [33] Graeff-Teixeira C, da Silva AC, Yoshimura K (Apr
O'Leary SJ (January 2008). “Can we prevent cochlear 2009). “Update on eosinophilic meningoencephalitis and
implant recipients from developing pneumococcal menin- its clinical relevance” (PDF). Clinical Microbiology Re-
gitis?" (PDF). Clin. Infect. Dis. 46 (1): e1–7. views 22 (2): 322–48. doi:10.1128/CMR.00044-08.
doi:10.1086/524083. PMID 18171202. PMC 2668237. PMID 19366917.
[37] Chaudhuri A; Martinez–Martin P; Martin PM; et al. [47] Segal S, Pollard AJ (2004). “Vaccines against bacterial
(July 2008). “EFNS guideline on the management of meningitis” (PDF). British Medical Bulletin 72 (1): 65–
community-acquired bacterial meningitis: report of an 81. doi:10.1093/bmb/ldh041. PMID 15802609.
EFNS Task Force on acute bacterial meningitis in older
children and adults”. European Journal of Neurolology [48] Peltola H (April 2000). “Worldwide Haemophilus in-
15 (7): 649–59. doi:10.1111/j.1468-1331.2008.02193.x. fluenzae type b disease at the beginning of the 21st cen-
PMID 18582342. tury: global analysis of the disease burden 25 years after
the use of the polysaccharide vaccine and a decade after
[38] Straus SE, Thorpe KE, Holroyd-Leduc J (October 2006). the advent of conjugates” (PDF). Clinical Microbiology
“How do I perform a lumbar puncture and analyze the Reviews 13 (2): 302–17. doi:10.1128/CMR.13.2.302-
results to diagnose bacterial meningitis?". Journal of 317.2000. PMC 100154. PMID 10756001.
the American Medical Association 296 (16): 2012–22. [49] Harrison LH (January 2006). “Prospects for vac-
doi:10.1001/jama.296.16.2012. PMID 17062865. cine prevention of meningococcal infection” (PDF).
Clinical Microbiology Reviews 19 (1): 142–64.
[39] Heyderman RS, Lambert HP, O'Sullivan I, Stuart JM, doi:10.1128/CMR.19.1.142-164.2006. PMC 1360272.
Taylor BL, Wall RA (February 2003). “Early manage- PMID 16418528.
ment of suspected bacterial meningitis and meningococ-
cal septicaemia in adults” (PDF). The Journal of infec- [50] Man, Diana. “A new MenB (meningococcal B) vaccine”.
tion 46 (2): 75–7. doi:10.1053/jinf.2002.1110. PMID Meningitis Research Foundation. Retrieved 23 November
12634067. – formal guideline at British Infection Soci- 2014.
ety & UK Meningitis Research Trust (December 2004).
[51] FDA News Release (29 October 2014). “First vaccine
“Early management of suspected meningitis and meningo-
approved by FDA to prevent serogroup B Meningococcal
coccal septicaemia in immunocompetent adults”. British
disease”. FDA.
Infection Society Guidelines. Retrieved 19 October 2008.
[52] Wilder-Smith A (October 2007). “Meningococcal vac-
[40] Maconochie IK, Bhaumik S (2014). Maconochie, Ian cine in travelers”. Current Opinion in Infectious Diseases
K, ed. “Fluid therapy for acute bacterial meningi- 20 (5): 454–60. doi:10.1097/QCO.0b013e3282a64700.
tis”. Cochrane Database of Systematic Reviews 5 (5): PMID 17762777.
CD004786. doi:10.1002/14651858.CD004786.pub4.
PMID 24793545. CD004786. [53] WHO (September 2000). “Detecting meningococcal
meningitis epidemics in highly-endemic African coun-
[41] Perfect JR, Dismukes WE, Dromer F, et al. (2010). tries” (PDF). Weekly Epidemiological Record 75 (38):
“Clinical practice guidelines for the management of cryp- 306–9. PMID 11045076.
tococcal disease: 2010 update by the infectious diseases
[54] Bishai, DM; Champion, C; Steele, ME; Thompson, L
society of america”. Clinical Infectious Diseases 50 (3):
(June 2011). “Product development partnerships hit their
291–322. doi:10.1086/649858. PMID 20047480.
stride: lessons from developing a meningitis vaccine for
Africa”. Health affairs (Project Hope) 30 (6): 1058–64.
[42] Sakushima, K; Hayashino, Y; Kawaguchi, T; Jack-
doi:10.1377/hlthaff.2011.0295. PMID 21653957.
son, JL; Fukuhara, S (April 2011). “Diagnostic ac-
curacy of cerebrospinal fluid lactate for differentiating [55] Marc LaForce, F; Ravenscroft, N; Djingarey, M; Viviani,
bacterial meningitis from aseptic meningitis: a meta- S (24 June 2009). “Epidemic meningitis due to Group
analysis”. The Journal of infection 62 (4): 255–62. A Neisseria meningitidis in the African meningitis belt: a
doi:10.1016/j.jinf.2011.02.010. PMID 21382412. persistent problem with an imminent solution”. Vaccine.
27 Suppl 2: B13–9. doi:10.1016/j.vaccine.2009.04.062.
[43] Bicanic T, Harrison TS (2004). “Cryptococcal menin- PMID 19477559.
gitis” (PDF). British Medical Bulletin 72 (1): 99–118.
doi:10.1093/bmb/ldh043. PMID 15838017. [56] Weisfelt M, de Gans J, van der Poll T, van de Beek D
(April 2006). “Pneumococcal meningitis in adults: new
[44] Sloan D, Dlamini S, Paul N, Dedicoat M (2008). approaches to management and prevention”. Lancet Neu-
Sloan, Derek, ed. “Treatment of acute crypto- rol 5 (4): 332–42. doi:10.1016/S1474-4422(06)70409-4.
coccal meningitis in HIV infected adults, with an PMID 16545750.
emphasis on resource-limited settings”. Cochrane [57] Zalmanovici Trestioreanu, A; Fraser, A; Gafter-Gvili,
Database of Systematic Reviews (4): CD005647. A; Paul, M; Leibovici, L (25 October 2013). “An-
doi:10.1002/14651858.CD005647.pub2. PMID tibiotics for preventing meningococcal infections.”.
18843697. CD005647. The Cochrane database of systematic reviews 10:
CD004785. doi:10.1002/14651858.CD004785.pub5.
[45] Warrell DA, Farrar JJ, Crook DWM (2003). “24.14.1 PMID 24163051.
Bacterial meningitis”. Oxford Textbook of Medicine Vol-
ume 3 (Fourth ed.). Oxford University Press. pp. 1115– [58] Ratilal, BO; Costa, J; Pappamikail, L; Sampaio, C
29. ISBN 0-19-852787-X. (28 April 2015). “Antibiotic prophylaxis for pre-
venting meningitis in patients with basilar skull frac-
[46] “CDC – Meningitis: Transmission”. Centers for Disease tures.”. The Cochrane database of systematic reviews
Control and Prevention (CDC). 6 August 2009. Retrieved 4: CD004884. doi:10.1002/14651858.CD004884.pub4.
18 June 2011. PMID 25918919.
12 10 REFERENCES
[59] Maconochie, IK; Bhaumik, S (May 5, 2014). “Fluid ther- [70] Chiang, SS; Khan, FA; Milstein, MB; Tolman, AW;
apy for acute bacterial meningitis.”. The Cochrane Benedetti, A; Starke, JR; Becerra, MC. “Treatment out-
database of systematic reviews 5: CD004786. comes of childhood tuberculous meningitis: a systematic
doi:10.1002/14651858.CD004786.pub4. PMID review and meta-analysis”. The Lancet Infectious Diseases
24793545. 14 (10): 947–957. doi:10.1016/S1473-3099(14)70852-
7.
[60] Prasad, K; Kumar, A; Gupta, PK; Singhal, T (17
October 2007). Prasad, Kameshwar, ed. “Third gen- [71] Lozano, R; Naghavi, M; Foreman, K; Lim, S; Shibuya, K;
eration cephalosporins versus conventional antibiotics Aboyans, V; Abraham, J; Adair, T; et al. (15 December
for treating acute bacterial meningitis”. Cochrane 2012). “Global and regional mortality from 235 causes of
database of systematic reviews (Online) (4): CD001832. death for 20 age groups in 1990 and 2010: a systematic
doi:10.1002/14651858.CD001832.pub3. PMID analysis for the Global Burden of Disease Study 2010”.
17943757. Lancet 380 (9859): 2095–128. doi:10.1016/S0140-
6736(12)61728-0. PMID 23245604.
[61] Brouwer, MC; McIntyre, P; Prasad, K; van de Beek, D (4 [72] Park, BJ; Wannemuehler, KA; Marston, BJ; Goven-
June 2013). “Corticosteroids for acute bacterial menin- der, N; Pappas, PG; Chiller, TM (Feb 20, 2009).
gitis.”. The Cochrane database of systematic reviews “Estimation of the current global burden of cryp-
6: CD004405. doi:10.1002/14651858.CD004405.pub4. tococcal meningitis among persons living with
PMID 23733364. HIV/AIDS.”. AIDS (London, England) 23 (4): 525–30.
doi:10.1097/QAD.0b013e328322ffac. PMID 19182676.
[62] Assiri AM, Alasmari FA, Zimmerman VA, Baddour LM,
Erwin PJ, Tleyjeh IM (May 2009). “Corticosteroid ad- [73] Lapeyssonnie L (1963). “Cerebrospinal meningitis in
ministration and outcome of adolescents and adults with Africa”. Bulletin of the World Health Organization
acute bacterial meningitis: a meta-analysis”. Mayo Clin. 28 (Suppl): SUPPL:1–114. PMC 2554630. PMID
Proc. 84 (5): 403–9. doi:10.4065/84.5.403. PMC 14259333.
2676122. PMID 19411436.
[74] Greenwood B (1999). “Manson Lecture. Meningococcal
[63] Prasad, K; Singh, MB (23 January 2008). Prasad, meningitis in Africa”. Trans. R. Soc. Trop. Med. Hyg.
Kameshwar, ed. “Corticosteroids for manag- 93 (4): 341–53. doi:10.1016/S0035-9203(99)90106-2.
ing tuberculous meningitis”. Cochrane database PMID 10674069.
of systematic reviews (Online) (1): CD002244. [75] World Health Organization (1998). Control of epidemic
doi:10.1002/14651858.CD002244.pub3. PMID meningococcal disease, practical guidelines, 2nd edition,
18254003. WHO/EMC/BA/98 (PDF) 3. pp. 1–83.
[64] de Gans J, van de Beek D (November 2002). “Dex- [76] WHO (2003). “Detecting meningococcal meningitis
amethasone in adults with bacterial meningitis”. The epidemics in highly-endemic African countries” (PDF).
New England Journal of Medicine 347 (20): 1549–56. Weekly Epidemiological Record 78 (33): 294–6. PMID
doi:10.1056/NEJMoa021334. PMID 12432041. 14509123.
[65] McIntyre PB; Berkey CS; King SM; et al. (Septem- [77] Arthur Earl Walker, Edward R. Laws, George B. Ud-
ber 1997). “Dexamethasone as adjunctive therapy varhelyi (1998). “Infections and inflammatory involve-
in bacterial meningitis. A meta-analysis of ran- ment of the CNS”. The Genesis of Neuroscience. Thieme.
domized clinical trials since 1988”. Journal of pp. 219–21. ISBN 1-879284-62-6.
the American Medical Association 278 (11): 925– [78] Whytt R (1768). Observations on the Dropsy in the Brain.
31. doi:10.1001/jama.1997.03550110063038. PMID Edinburgh: J. Balfour.
9302246.
[79] Greenwood B (June 2006). “100 years of epidemic
[66] “Meningitis and Encephalitis Fact Sheet”. National Insti- meningitis in West Africa – has anything changed?".
tute of Neurological Disorders and Stroke (NINDS). 11 Tropical Medicine & International health: TM & IH 11
December 2007. Retrieved 27 April 2009. (6): 773–80. doi:10.1111/j.1365-3156.2006.01639.x.
PMID 16771997.
[67] Gottfredsson M, Perfect JR (2000). “Fungal meningitis”.
Seminars in Neurology 20 (3): 307–22. doi:10.1055/s- [80] Vieusseux G (1806). “Mémoire sur le Maladie qui a regne
2000-9394. PMID 11051295. à Génève au printemps de 1805”. Journal de Médecine, de
Chirurgie et de Pharmacologie (Bruxelles) (in French) 11:
[68] “Mortality and Burden of Disease Estimates for WHO 50–53.
Member States in 2002” (xls). World Health Organiza- [81] Weichselbaum A (1887). “Ueber die Aetiologie der
tion (WHO). 2002. akuten Meningitis cerebro-spinalis”. Fortschrift der Medi-
zin (in German) 5: 573–583.
[69] Richardson MP, Reid A, Tarlow MJ, Rudd PT (Febru-
ary 1997). “Hearing loss during bacterial meningitis” [82] Flexner S (1913). “The results of the serum treatment
(PDF). Archives of Disease in Childhood 76 (2): 134– in thirteen hundred cases of epidemic meningitis” (PDF).
38. doi:10.1136/adc.76.2.134. PMC 1717058. PMID J Exp Med 17 (5): 553–76. doi:10.1084/jem.17.5.553.
9068303. PMC 2125091. PMID 19867668.
13
11 External links
• Meningitis at DMOZ
• Meningitis Centers for Disease Control and Preven-
tion (CDC)
14 12 TEXT AND IMAGE SOURCES, CONTRIBUTORS, AND LICENSES
12.2 Images
• File:Ceftriaxone_structure.png Source: https://upload.wikimedia.org/wikipedia/commons/0/0c/Ceftriaxone_structure.png License:
Public domain Contributors: Own work Original artist: Edgar181
12.3 Content license 15